BTI
COGT icon

Blue Trust Inc’s Cogent Biosciences COGT Stock Holding History

Blue Trust Inc’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.15K Buy
+133
New +$4.65K ﹤0.01% 2018
2023
Q1 		– Sell
-117
Closed -$2K – 2348
2022
Q4 		$2K Buy
117
+40
+52% +$496 ﹤0.01% 1908
2022
Q3 		$1K Buy
77
+22
+40% +$302 ﹤0.01% 1898
2022
Q2 		$0 Buy
+55
New +$375 ﹤0.01% 1904

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Blue Trust Inc's COGT Position: Q2 2026 in Review

Blue Trust Inc opened a new position in Cogent Biosciences (COGT) in Q2 2026: 133 shares worth $5.15K. The stake represents ﹤0.01% of the portfolio and ranks #2018 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in COGT as recently as Q4 2022.

Blue Trust Inc first reported a position in COGT in Q2 2022 and has held it in 4 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Blue Trust Inc held 133 shares of Cogent Biosciences worth $5.15K as of Q2 2026.
  • Cogent Biosciences was a new Blue Trust Inc position in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2018 holding.
  • Blue Trust Inc first reported a position in Cogent Biosciences in Q2 2022 and has held it in 4 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.